AU508229B2 - Cyclic amino acid derivatives - Google Patents

Cyclic amino acid derivatives

Info

Publication number
AU508229B2
AU508229B2 AU26024/77A AU2602477A AU508229B2 AU 508229 B2 AU508229 B2 AU 508229B2 AU 26024/77 A AU26024/77 A AU 26024/77A AU 2602477 A AU2602477 A AU 2602477A AU 508229 B2 AU508229 B2 AU 508229B2
Authority
AU
Australia
Prior art keywords
amino acid
acid derivatives
cyclic amino
cyclic
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU26024/77A
Other languages
English (en)
Other versions
AU2602477A (en
Inventor
J. Fatzinger G. and Herrmann M. F. R Hartenstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of AU2602477A publication Critical patent/AU2602477A/en
Application granted granted Critical
Publication of AU508229B2 publication Critical patent/AU508229B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU26024/77A 1976-06-12 1977-06-10 Cyclic amino acid derivatives Expired AU508229B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2626467A DE2626467C2 (de) 1976-06-12 1976-06-12 1-(N-Isopropylaminomethyl)-cyclohexanessigsäure, Verfahren zu deren Herstellung und diese Verbindung enthaltende Arzneimittel
DEDE2626467 1976-06-12

Publications (2)

Publication Number Publication Date
AU2602477A AU2602477A (en) 1978-12-14
AU508229B2 true AU508229B2 (en) 1980-03-13

Family

ID=5980432

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26024/77A Expired AU508229B2 (en) 1976-06-12 1977-06-10 Cyclic amino acid derivatives

Country Status (4)

Country Link
JP (1) JPS52153946A (th)
AU (1) AU508229B2 (th)
CA (1) CA1094097A (th)
DE (1) DE2626467C2 (th)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02132299A (ja) * 1988-11-14 1990-05-21 Tokai Rubber Ind Ltd 防水工法
AU633612B2 (en) * 1989-08-25 1993-02-04 Warner-Lambert Company Improved process for cyclic amino acid anticonvulsant compounds
DE3928182A1 (de) * 1989-08-25 1991-02-28 Goedecke Ag Verfahren zur herstellung von gabapentin
HU224720B1 (en) * 1996-03-14 2006-01-30 Warner Lambert Co Novel substituted cyclic amino acid derivatives use as pharmaceutical agents
GB2362646A (en) * 2000-05-26 2001-11-28 Warner Lambert Co Cyclic amino acid derivatives useful as pharmaceutical agents

Also Published As

Publication number Publication date
CA1094097A (en) 1981-01-20
DE2626467A1 (de) 1977-12-29
DE2626467C2 (de) 1984-11-22
JPS5633385B2 (th) 1981-08-03
AU2602477A (en) 1978-12-14
JPS52153946A (en) 1977-12-21

Similar Documents

Publication Publication Date Title
AU513892B2 (en) Cyclic amino acid derivatives
AU511853B2 (en) l-Phenyl-2-Oxo-Pyrroliaine-4-carboxylic acid derivatives
AU510868B2 (en) Phenoxy-phenoxy-propionic acid derivatives
AU503934B2 (en) Amino chomanols
AU510760B2 (en) Peptide derivatives
AU501066B2 (en) Fudidic acid derivatives
AU5415686A (en) 2-hydroxy-4-trifluoromethylbenzoic acid derivatives
AU521207B2 (en) PYRAZOL-l-YL-PHENYLAC ACID DERIVATIVES
AU497932B2 (en) Phenoxyalkylcarboxylic acid derivatives
AU500761B2 (en) Phenoxyalkylcarboxylic acid derivatives
AU510077B2 (en) Dipeptide derivatives
AU517209B2 (en) Benz-acyl-benzimidazole-2-carboxylic acid derivatives
AU503873B2 (en) Substituted ureidoacethydroxamic acid
ZA774388B (en) Novel phenoxy-phenoxy-alkanecarboxylic acid derivatives
AU514895B2 (en) Hydroxyaminohydrocarbonphosphonic acid derivatives
AU518251B2 (en) L-halomethyl amino acid derivatives
AU508229B2 (en) Cyclic amino acid derivatives
AU504699B2 (en) Phenoxyphenoxy-alkanecarboxylic acid derivatives
AU513600B2 (en) Hydroxamic acid derivatives
AU500980B2 (en) Oxanilic acid derivatives
AU511452B2 (en) Peptide derivatives
JPS5287142A (en) New cyclic amino acid
AU512159B2 (en) Phenoxy-phenoxy-alkanecarboxylic acid derivatives
AU517211B2 (en) 2-amino-cyclopent-1-ene-1-dithiocarboxylic acid derivatives
AU517325B2 (en) Thiosubstituted carbamic acid derivatives